<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37408276</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Roles of Aging, Circular RNAs, and RNA Editing in the Pathogenesis of Amyotrophic Lateral Sclerosis: Potential Biomarkers and Therapeutic Targets.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1443</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12101443</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is an incurable motor neuron disease caused by upper and lower motor neuron death. Despite advances in our understanding of ALS pathogenesis, effective treatment for this fatal disease remains elusive. As aging is a major risk factor for ALS, age-related molecular changes may provide clues for the development of new therapeutic strategies. Dysregulation of age-dependent RNA metabolism plays a pivotal role in the pathogenesis of ALS. In addition, failure of RNA editing at the glutamine/arginine (Q/R) site of GluA2 mRNA causes excitotoxicity due to excessive Ca<sup>2+</sup> influx through Ca<sup>2+</sup>-permeable &#x3b1;-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors, which is recognized as an underlying mechanism of motor neuron death in ALS. Circular RNAs (circRNAs), a circular form of cognate RNA generated by back-splicing, are abundant in the brain and accumulate with age. Hence, they are assumed to play a role in neurodegeneration. Emerging evidence has demonstrated that age-related dysregulation of RNA editing and changes in circRNA expression are involved in ALS pathogenesis. Herein, we review the potential associations between age-dependent changes in circRNAs and RNA editing, and discuss the possibility of developing new therapies and biomarkers for ALS based on age-related changes in circRNAs and dysregulation of RNA editing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hosaka</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0305-8809</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Tsukuba Hospital/Jichi Medical University Joint Ibaraki Western Regional Clinical Education Center, Chikusei 308-0813, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Ibaraki Western Medical Center, Chikusei 308-0813, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuji</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Shin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Medical University, Tokyo 160-0023, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000079962">RNA, Circular</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079962" MajorTopicYN="N">RNA, Circular</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017393" MajorTopicYN="N">RNA Editing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA editing</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">brain aging</Keyword><Keyword MajorTopicYN="N">circular RNA</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37408276</ArticleId><ArticleId IdType="pmc">PMC10216766</ArticleId><ArticleId IdType="doi">10.3390/cells12101443</ArticleId><ArticleId IdType="pii">cells12101443</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland L.P., Shneider N.A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman E.L., Goutman S.A., Petri S., Mazzini L., Savelieff M.G., Shaw P.J., Sobue G. Amyotrophic Lateral Sclerosis. Lancet. 2022;400:1363&#x2013;1380. doi: 10.1016/S0140-6736(22)01272-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01272-7</ArticleId><ArticleId IdType="pmc">PMC10089700</ArticleId><ArticleId IdType="pubmed">36116464</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur K.C., Calvo A., Price T.R., Geiger J.T., Chi&#xf2; A., Traynor B.J. Projected Increase in Amyotrophic Lateral Sclerosis from 2015 to 2040. Nat. Commun. 2016;7:12408. doi: 10.1038/ncomms12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman S.A., Hardiman O., Al-Chalabi A., Chi&#xf3; A., Savelieff M.G., Kiernan M.C., Feldman E.L. Emerging Insights into the Complex Genetics and Pathophysiology of Amyotrophic Lateral Sclerosis. Lancet Neurol. 2022;21:465&#x2013;479. doi: 10.1016/S1474-4422(21)00414-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00414-2</ArticleId><ArticleId IdType="pmc">PMC9513754</ArticleId><ArticleId IdType="pubmed">35334234</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA Dysregulation in Amyotrophic Lateral Sclerosis. Front. Genet. 2018;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner J.M., Bedlack R., Andrews J.A., Berry J.D., Bowser R., Brown R., Glass J.D., Maragakis N.J., Miller T.M., Rothstein J.D., et al. Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review. JAMA Neurol. 2022;79:1312&#x2013;1318. doi: 10.1001/jamaneurol.2022.3282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.3282</ArticleId><ArticleId IdType="pubmed">36251310</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez L., Bensimon G., Leigh P.N., Guillet P., Meininger V. Dose-Ranging Study of Riluzole in Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347:1425&#x2013;1431. doi: 10.1016/S0140-6736(96)91680-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)91680-3</ArticleId><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Group. Edaravone (MCI-186) ALS 19 Study Group Safety and Efficacy of Edaravone in Well Defined Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Macklin E.A., Hendrix S., Berry J.D., Elliott M.A., Maiser S., Karam C., Caress J.B., Owegi M.A., Quick A., et al. Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2020;383:919&#x2013;930. doi: 10.1056/NEJMoa1916945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1916945</ArticleId><ArticleId IdType="pmc">PMC9134321</ArticleId><ArticleId IdType="pubmed">32877582</ArticleId></ArticleIdList></Reference><Reference><Citation>Harries L.W., Hernandez D., Henley W., Wood A.R., Holly A.C., Bradley-Smith R.M., Yaghootkar H., Dutta A., Murray A., Frayling T.M., et al. Human Aging Is Characterized by Focused Changes in Gene Expression and Deregulation of Alternative Splicing. Aging Cell. 2011;10:868&#x2013;878. doi: 10.1111/j.1474-9726.2011.00726.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2011.00726.x</ArticleId><ArticleId IdType="pmc">PMC3173580</ArticleId><ArticleId IdType="pubmed">21668623</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;nerta&#x15f; H.M., &#x130;zgi H., Kamac&#x131;o&#x11f;lu A., He Z., Khaitovich P., Somel M. Gene Expression Reversal Toward Pre-adult Levels in the Aging Human Brain and Age-Related Loss of Cellular Identity. Sci. Rep. 2017;7:5894. doi: 10.1038/s41598-017-05927-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05927-4</ArticleId><ArticleId IdType="pmc">PMC5517654</ArticleId><ArticleId IdType="pubmed">28724976</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker D.J., Petersen R.C. Cellular Senescence in Brain Aging and Neurodegenerative Diseases: Evidence and Perspectives. J. Clin. Investig. 2018;128:1208&#x2013;1216. doi: 10.1172/JCI95145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI95145</ArticleId><ArticleId IdType="pmc">PMC5873891</ArticleId><ArticleId IdType="pubmed">29457783</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y., Dan X., Babbar M., Wei Y., Hasselbalch S.G., Croteau D.L., Bohr V.A. Ageing as a Risk Factor for Neurodegenerative Disease. Nat. Rev. Neurol. 2019;15:565&#x2013;581. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun S., Domdey H., Wiebauer K. Inverse Splicing of a Discontinuous Pre-mRNA Intron Generates a Circular Exon in a HeLa Cell Nuclear Extract. Nucleic Acids Res. 1996;24:4152&#x2013;4157. doi: 10.1093/nar/24.21.4152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/24.21.4152</ArticleId><ArticleId IdType="pmc">PMC146224</ArticleId><ArticleId IdType="pubmed">8932365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashwal-Fluss R., Meyer M., Pamudurti N.R., Ivanov A., Bartok O., Hanan M., Evantal N., Memczak S., Rajewsky N., Kadener S. circRNA Biogenesis Competes with Pre-mRNA Splicing. Mol. Cell. 2014;56:55&#x2013;66. doi: 10.1016/j.molcel.2014.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.08.019</ArticleId><ArticleId IdType="pubmed">25242144</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng S., Zhou H., Feng Z., Xu Z., Tang Y., Li P., Wu M. CircRNA: Functions and Properties of a Novel Potential Biomarker for Cancer. Mol. Cancer. 2017;16:94. doi: 10.1186/s12943-017-0663-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-017-0663-2</ArticleId><ArticleId IdType="pmc">PMC5440908</ArticleId><ArticleId IdType="pubmed">28535767</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren S., Lin P., Wang J., Yu H., Lv T., Sun L., Du G. Circular RNAs: Promising Molecular Biomarkers of Human Aging-Related Diseases via Functioning as An miRNA Sponge. Mol. Ther. Methods Clin. Dev. 2020;18:215&#x2013;229. doi: 10.1016/j.omtm.2020.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2020.05.027</ArticleId><ArticleId IdType="pmc">PMC7326721</ArticleId><ArticleId IdType="pubmed">32637451</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yao L., Tang Y., Jhong J.H., Wan J., Chang J., Cui S., Luo Y., Cai X., Li W., et al. CircNet 2.0: An Updated Database for Exploring Circular RNA Regulatory Networks in Cancers. Nucleic Acids Res. 2022;50:D93&#x2013;D101. doi: 10.1093/nar/gkab1036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1036</ArticleId><ArticleId IdType="pmc">PMC8728223</ArticleId><ArticleId IdType="pubmed">34850139</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoudi E., Cairns M.J. Circular RNAs Are Temporospatially Regulated Throughout Development and Ageing in the Rat. Sci. Rep. 2019;9:2564. doi: 10.1038/s41598-019-38860-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-38860-9</ArticleId><ArticleId IdType="pmc">PMC6385508</ArticleId><ArticleId IdType="pubmed">30796328</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeck W.R., Sorrentino J.A., Wang K., Slevin M.K., Burd C.E., Liu J., Marzluff W.F., Sharpless N.E. Circular RNAs Are Abundant, Conserved, and Associated with ALU Repeats. RNA. 2013;19:141&#x2013;157. doi: 10.1261/rna.035667.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.035667.112</ArticleId><ArticleId IdType="pmc">PMC3543092</ArticleId><ArticleId IdType="pubmed">23249747</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdt L.M., Stahringer A., Sass K., Pichler G., Kulak N.A., Wilfert W., Kohlmaier A., Herbst A., Northoff B.H., Nicolaou A., et al. Circular Non-coding RNA ANRIL Modulates Ribosomal RNA Maturation and Atherosclerosis in Humans. Nat. Commun. 2016;7:12429. doi: 10.1038/ncomms12429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12429</ArticleId><ArticleId IdType="pmc">PMC4992165</ArticleId><ArticleId IdType="pubmed">27539542</ArticleId></ArticleIdList></Reference><Reference><Citation>Rybak-Wolf A., Stottmeister C., Gla&#x17e;ar P., Jens M., Pino N., Giusti S., Hanan M., Behm M., Bartok O., Ashwal-Fluss R., et al. Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. Mol. Cell. 2015;58:870&#x2013;885. doi: 10.1016/j.molcel.2015.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.03.027</ArticleId><ArticleId IdType="pubmed">25921068</ArticleId></ArticleIdList></Reference><Reference><Citation>Vo J.N., Cieslik M., Zhang Y., Shukla S., Xiao L., Zhang Y., Wu Y.M., Dhanasekaran S.M., Engelke C.G., Cao X., et al. The Landscape of Circular RNA in Cancer. Cell. 2019;176:869&#x2013;881.e13. doi: 10.1016/j.cell.2018.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.12.021</ArticleId><ArticleId IdType="pmc">PMC6601354</ArticleId><ArticleId IdType="pubmed">30735636</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Huang C., Bao C., Chen L., Lin M., Wang X., Zhong G., Yu B., Hu W., Dai L., et al. Exon-Intron Circular RNAs Regulate Transcription in the Nucleus. Nat. Struct. Mol. Biol. 2015;22:256&#x2013;264. doi: 10.1038/nsmb.2959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2959</ArticleId><ArticleId IdType="pubmed">25664725</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Su H., Zhang J., Liu Y., Feng C., Han F. Back-Spliced RNA from Retrotransposon Binds to Centromere and Regulates Centromeric Chromatin Loops in Maize. PLoS Biol. 2020;18:e3000582. doi: 10.1371/journal.pbio.3000582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000582</ArticleId><ArticleId IdType="pmc">PMC7010299</ArticleId><ArticleId IdType="pubmed">31995554</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen T.B., Jensen T.I., Clausen B.H., Bramsen J.B., Finsen B., Damgaard C.K., Kjems J. Natural RNA Circles Function as Efficient microRNA Sponges. Nature. 2013;495:384&#x2013;388. doi: 10.1038/nature11993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11993</ArticleId><ArticleId IdType="pubmed">23446346</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W.W., Yang W., Liu E., Yang Z., Dhaliwal P., Yang B.B. Foxo3 Circular RNA Retards Cell Cycle Progression via Forming Ternary Complexes with p21 and CDK2. Nucleic Acids Res. 2016;44:2846&#x2013;2858. doi: 10.1093/nar/gkw027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw027</ArticleId><ArticleId IdType="pmc">PMC4824104</ArticleId><ArticleId IdType="pubmed">26861625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruner H., Cort&#xe9;s-L&#xf3;pez M., Cooper D.A., Bauer M., Miura P. CircRNA Accumulation in the Aging Mouse Brain. Sci. Rep. 2016;6:38907. doi: 10.1038/srep38907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep38907</ArticleId><ArticleId IdType="pmc">PMC5153657</ArticleId><ArticleId IdType="pubmed">27958329</ArticleId></ArticleIdList></Reference><Reference><Citation>You X., Vlatkovic I., Babic A., Will T., Epstein I., Tushev G., Akbalik G., Wang M., Glock C., Quedenau C., et al. Neural Circular RNAs Are Derived from Synaptic Genes and Regulated by Development and Plasticity. Nat. Neurosci. 2015;18:603&#x2013;610. doi: 10.1038/nn.3975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3975</ArticleId><ArticleId IdType="pmc">PMC4376664</ArticleId><ArticleId IdType="pubmed">25714049</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Anca M., Buccellato F.R., Fenoglio C., Galimberti D. Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration. Int. J. Mol. Sci. 2022;23:4134. doi: 10.3390/ijms23084134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23084134</ArticleId><ArticleId IdType="pmc">PMC9032451</ArticleId><ArticleId IdType="pubmed">35456950</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D.P., Zhao Y.D., Yan Q.Q., Liu L.L., Wei Y.S., Huang J.L. Circular RNAs: Emerging Players in Brain Aging and Neurodegenerative Diseases. J. Pathol. 2023;259:1&#x2013;9. doi: 10.1002/path.6021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.6021</ArticleId><ArticleId IdType="pubmed">36264226</ArticleId></ArticleIdList></Reference><Reference><Citation>Azam S., Haque M.E., Balakrishnan R., Kim I.S., Choi D.K. The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration. Front. Cell Dev. Biol. 2021;9:683459. doi: 10.3389/fcell.2021.683459.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.683459</ArticleId><ArticleId IdType="pmc">PMC8414981</ArticleId><ArticleId IdType="pubmed">34485280</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Zheng Q., Bao C., Li S., Guo W., Zhao J., Chen D., Gu J., He X., Huang S. Circular RNA Is Enriched and Stable in Exosomes: A Promising Biomarker for Cancer Diagnosis. Cell Res. 2015;25:981&#x2013;984. doi: 10.1038/cr.2015.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2015.82</ArticleId><ArticleId IdType="pmc">PMC4528056</ArticleId><ArticleId IdType="pubmed">26138677</ArticleId></ArticleIdList></Reference><Reference><Citation>Maass P.G., Gla&#x17e;ar P., Memczak S., Dittmar G., Hollfinger I., Schreyer L., Sauer A.V., Toka O., Aiuti A., Luft F.C., et al. A Map of Human Circular RNAs in Clinically Relevant Tissues. J. Mol. Med. 2017;95:1179&#x2013;1189. doi: 10.1007/s00109-017-1582-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-017-1582-9</ArticleId><ArticleId IdType="pmc">PMC5660143</ArticleId><ArticleId IdType="pubmed">28842720</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikura K. A-to-I Editing of Coding and Non-coding RNAs by ADARs. Nat. Rev. Mol. Cell Biol. 2016;17:83&#x2013;96. doi: 10.1038/nrm.2015.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2015.4</ArticleId><ArticleId IdType="pmc">PMC4824625</ArticleId><ArticleId IdType="pubmed">26648264</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueter S.M., Dawson T.R., Emeson R.B. Regulation of Alternative Splicing by RNA Editing. Nature. 1999;399:75&#x2013;80. doi: 10.1038/19992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/19992</ArticleId><ArticleId IdType="pubmed">10331393</ArticleId></ArticleIdList></Reference><Reference><Citation>Heraud-Farlow J.E., Walkley C.R. What Do Editors Do? Understanding the Physiological Functions of A-to-I RNA Editing by Adenosine Deaminase Acting on RNAs. Open Biol. 2020;10:200085. doi: 10.1098/rsob.200085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.200085</ArticleId><ArticleId IdType="pmc">PMC7574547</ArticleId><ArticleId IdType="pubmed">32603639</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Chendrimada T.P., Wang Q., Higuchi M., Seeburg P.H., Shiekhattar R., Nishikura K. Modulation of microRNA Processing and Expression Through RNA Editing by ADAR Deaminases. Nat. Struct. Mol. Biol. 2006;13:13&#x2013;21. doi: 10.1038/nsmb1041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1041</ArticleId><ArticleId IdType="pmc">PMC2950615</ArticleId><ArticleId IdType="pubmed">16369484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov A., Memczak S., Wyler E., Torti F., Porath H.T., Orejuela M.R., Piechotta M., Levanon E.Y., Landthaler M., Dieterich C., et al. Analysis of Intron Sequences Reveals Hallmarks of Circular RNA Biogenesis in Animals. Cell Rep. 2015;10:170&#x2013;177. doi: 10.1016/j.celrep.2014.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.12.019</ArticleId><ArticleId IdType="pubmed">25558066</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C., Ma Y.Y. Calcium Permeable-AMPA Receptors and Excitotoxicity in Neurological Disorders. Front. Neural Circuits. 2021;15:711564. doi: 10.3389/fncir.2021.711564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2021.711564</ArticleId><ArticleId IdType="pmc">PMC8416103</ArticleId><ArticleId IdType="pubmed">34483848</ArticleId></ArticleIdList></Reference><Reference><Citation>Greger I.H., Khatri L., Ziff E.B. RNA Editing at arg607 Controls AMPA Receptor Exit from the Endoplasmic Reticulum. Neuron. 2002;34:759&#x2013;772. doi: 10.1016/S0896-6273(02)00693-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00693-1</ArticleId><ArticleId IdType="pubmed">12062022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hideyama T., Teramoto S., Hachiga K., Yamashita T., Kwak S. Co-occurrence of TDP-43 Mislocalization with Reduced Activity of an RNA Editing Enzyme, ADAR2, in Aged Mouse Motor Neurons. PLoS ONE. 2012;7:e43469. doi: 10.1371/journal.pone.0043469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043469</ArticleId><ArticleId IdType="pmc">PMC3423340</ArticleId><ArticleId IdType="pubmed">22916266</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao X., Shiromoto Y., Sakurai M., Towers M., Zhang Q., Wu S., Havas A., Wang L., Berger S., Adams P.D., et al. ADAR1 Downregulation by Autophagy Drives Senescence Independently of RNA Editing by Enhancing p16INK4a Levels. Nat. Cell Biol. 2022;24:1202&#x2013;1210. doi: 10.1038/s41556-022-00959-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-022-00959-z</ArticleId><ArticleId IdType="pmc">PMC9757154</ArticleId><ArticleId IdType="pubmed">35851616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebastiani P., Montano M., Puca A., Solovieff N., Kojima T., Wang M.C., Melista E., Meltzer M., Fischer S.E., Andersen S., et al. RNA Editing Genes Associated with Extreme Old Age in Humans and with Lifespan in C. elegans. PLoS ONE. 2009;4:e8210. doi: 10.1371/annotation/387f8074-5f80-4bdd-bb0b-b36d49a16ac0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/annotation/387f8074-5f80-4bdd-bb0b-b36d49a16ac0</ArticleId><ArticleId IdType="pmc">PMC2788130</ArticleId><ArticleId IdType="pubmed">20011587</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;nard C., Quirion R., Vigneault E., Bouchard S., Ferland G., El Mestikawy S., Gaudreau P. Glutamate Presynaptic Vesicular Transporter and Postsynaptic Receptor Levels Correlate with Spatial Memory Status in Aging Rat Models. Neurobiol. Aging. 2015;36:1471&#x2013;1482. doi: 10.1016/j.neurobiolaging.2014.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.11.013</ArticleId><ArticleId IdType="pubmed">25556161</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurado S. AMPA Receptor Trafficking in Natural and Pathological Aging. Front. Mol. Neurosci. 2017;10:446. doi: 10.3389/fnmol.2017.00446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00446</ArticleId><ArticleId IdType="pmc">PMC5767248</ArticleId><ArticleId IdType="pubmed">29375307</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiapaer Z., Su D., Hua L., Lehmann H.I., Gokulnath P., Vulugundam G., Song S., Zhang L., Gong Y., Li G. Regulation and roles of RNA modifications in aging-related diseases. Aging Cell. 2022;21:e13657. doi: 10.1111/acel.13657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13657</ArticleId><ArticleId IdType="pmc">PMC9282851</ArticleId><ArticleId IdType="pubmed">35718942</ArticleId></ArticleIdList></Reference><Reference><Citation>Du S., Zheng H. Role of FoxO Transcription Factors in Aging and Age-Related Metabolic and Neurodegenerative Diseases. Cell Biosci. 2021;11:188. doi: 10.1186/s13578-021-00700-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-021-00700-7</ArticleId><ArticleId IdType="pmc">PMC8561869</ArticleId><ArticleId IdType="pubmed">34727995</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W.W., Yang W., Chen Y., Wu Z.K., Foster F.S., Yang Z., Li X., Yang B.B. Foxo3 Circular RNA Promotes Cardiac Senescence by Modulating Multiple Factors Associated with Stress and Senescence Responses. Eur. Heart J. 2017;38:1402&#x2013;1412. doi: 10.1093/eurheartj/ehw001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw001</ArticleId><ArticleId IdType="pubmed">26873092</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque S., Ames R.M., Moore K., Pilling L.C., Peters L.L., Bandinelli S., Ferrucci L., Harries L.W. circRNAs Expressed in Human Peripheral Blood Are Associated with Human Aging Phenotypes, Cellular Senescence and Mouse Lifespan. GeroScience. 2020;42:183&#x2013;199. doi: 10.1007/s11357-019-00120-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-019-00120-z</ArticleId><ArticleId IdType="pmc">PMC7031184</ArticleId><ArticleId IdType="pubmed">31811527</ArticleId></ArticleIdList></Reference><Reference><Citation>Roush S., Slack F.J. The Let-7 Family of microRNAs. Trends Cell Biol. 2008;18:505&#x2013;516. doi: 10.1016/j.tcb.2008.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2008.07.007</ArticleId><ArticleId IdType="pubmed">18774294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann S.M., Kr&#xfc;ger C., Park B., Derkow K., Rosenberger K., Baumgart J., Trimbuch T., Eom G., Hinz M., Kaul D., et al. An Unconventional Role for miRNA: Let-7 Activates Toll-Like Receptor 7 and Causes Neurodegeneration. Nat. Neurosci. 2012;15:827&#x2013;835. doi: 10.1038/nn.3113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3113</ArticleId><ArticleId IdType="pubmed">22610069</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Y., Lin W., Zhan L., Zhang J., Zhang S., Jin H., Zhang H., Wang X., Li X. Inhibiting Autophagy Pathway of PI3K/AKT/mTOR Promotes Apoptosis in SK-N-SH Cell Model of Alzheimer&#x2019;s Disease. J. Healthc. Eng. 2022;2022:6069682. doi: 10.1155/2022/6069682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/6069682</ArticleId><ArticleId IdType="pmc">PMC8846974</ArticleId><ArticleId IdType="pubmed">35178230</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda A.C., Grammatikakis I., Kim K.M., De S., Martindale J.L., Munk R., Yang X., Abdelmohsen K., Gorospe M. Identification of Senescence-Associated Circular RNAs (SAC-RNAs) Reveals Senescence Suppressor CircPVT1. Nucleic Acids Res. 2017;45:4021&#x2013;4035. doi: 10.1093/nar/gkw1201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1201</ArticleId><ArticleId IdType="pmc">PMC5397146</ArticleId><ArticleId IdType="pubmed">27928058</ArticleId></ArticleIdList></Reference><Reference><Citation>Han W., Tao X., Weng T., Chen L. Circular RNA PVT1 Inhibits Tendon Stem/Progenitor Cell Senescence by Sponging microRNA-199a-5p. Toxicol. Vitr. 2022;79:105297. doi: 10.1016/j.tiv.2021.105297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tiv.2021.105297</ArticleId><ArticleId IdType="pubmed">34896603</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#x119;&#x15b;ko H., Wencel P., Strosznajder R.P., Strosznajder J.B. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders. Neurochem. Res. 2017;42:876&#x2013;890. doi: 10.1007/s11064-016-2110-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-016-2110-y</ArticleId><ArticleId IdType="pmc">PMC5357501</ArticleId><ArticleId IdType="pubmed">27882448</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa C., Mendes A.F. Monoterpenes as Sirtuin-1 Activators: Therapeutic Potential in Aging and Related Diseases. Biomolecules. 2022;12:921. doi: 10.3390/biom12070921.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12070921</ArticleId><ArticleId IdType="pmc">PMC9313249</ArticleId><ArticleId IdType="pubmed">35883477</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulias K., Greer E.L. Biological Roles of Adenine Methylation in RNA. Nat. Rev. Genet. 2023;24:143&#x2013;160. doi: 10.1038/s41576-022-00534-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-022-00534-0</ArticleId><ArticleId IdType="pmc">PMC9974562</ArticleId><ArticleId IdType="pubmed">36261710</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu T., He B., Sun H., Xiong M., Nie J., Wang S., Pan Y. Novel Insights into the Interaction Between N6-Methyladenosine Modification and Circular RNA. Mol. Ther. Nucleic Acids. 2022;27:824&#x2013;837. doi: 10.1016/j.omtn.2022.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2022.01.007</ArticleId><ArticleId IdType="pmc">PMC8807973</ArticleId><ArticleId IdType="pubmed">35141044</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Yang S., Han S., Sun Y., Han M., Zheng X., Li F., Wei Y., Wang Y., Bi J. Differential Methylation of circRNA m6A in an APP/PS1 Alzheimer&#x2019;s Disease Mouse Model. Mol. Med. Rep. 2023;27:1&#x2013;8. doi: 10.3892/mmr.2023.12942.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2023.12942</ArticleId><ArticleId IdType="pmc">PMC9879070</ArticleId><ArticleId IdType="pubmed">36660942</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer C., Pitschelatow G., Hannemann N., Linde J., Reichard J., Pensold D., Zimmer-Bensch G. DNA Methyltransferase 1 (DNMT1) Acts on Neurodegeneration by Modulating Proteostasis-Relevant Intracellular Processes. Int. J. Mol. Sci. 2020;21:5420. doi: 10.3390/ijms21155420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155420</ArticleId><ArticleId IdType="pmc">PMC7432412</ArticleId><ArticleId IdType="pubmed">32751461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutnick L.K., Golshani P., Namihira M., Xue Z., Matynia A., Yang X.W., Silva A.J., Schweizer F.E., Fan G. DNA Hypomethylation Restricted to the Murine Forebrain Induces Cortical Degeneration and Impairs Postnatal Neuronal Maturation. Hum. Mol. Genet. 2009;18:2875&#x2013;2888. doi: 10.1093/hmg/ddp222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp222</ArticleId><ArticleId IdType="pmc">PMC2706688</ArticleId><ArticleId IdType="pubmed">19433415</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensold D., Symmank J., Hahn A., Lingner T., Salinas-Riester G., Downie B.R., Ludewig F., Rotzsch A., Haag N., Andreas N., et al. The DNA Methyltransferase 1 (DNMT1) Controls the Shape and Dynamics of Migrating POA-Derived Interneurons Fated for the Murine Cerebral Cortex. Cereb. Cortex. 2017;27:5696&#x2013;5714. doi: 10.1093/cercor/bhw341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhw341</ArticleId><ArticleId IdType="pubmed">29117290</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Zhao X., Shao Y., Duan X., Wang Y., Li J., Li J., Li D., Li X., Wong J. Mutation-Induced DNMT1 Cleavage Drives Neurodegenerative Disease. Sci. Adv. 2021;7:eabe8511. doi: 10.1126/sciadv.abe8511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe8511</ArticleId><ArticleId IdType="pmc">PMC8442919</ArticleId><ArticleId IdType="pubmed">34516921</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W.W., Yang W., Li X., Awan F.M., Yang Z., Fang L., Lyu J., Li F., Peng C., Krylov S.N., et al. A Circular RNA Circ-DNMT1 Enhances Breast Cancer Progression by Activating Autophagy. Oncogene. 2018;37:5829&#x2013;5842. doi: 10.1038/s41388-018-0369-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-018-0369-y</ArticleId><ArticleId IdType="pubmed">29973691</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K., Zhang Y., Xiong W., Zhang Z., Wang Z., Lv L., Liu C., Hu Z., Zheng Y.T., Lu L., et al. CircGRIA1 Shows an Age-Related Increase in Male Macaque Brain and Regulates Synaptic Plasticity and Synaptogenesis. Nat. Commun. 2020;11:3594. doi: 10.1038/s41467-020-17435-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17435-7</ArticleId><ArticleId IdType="pmc">PMC7367861</ArticleId><ArticleId IdType="pubmed">32681011</ArticleId></ArticleIdList></Reference><Reference><Citation>Dluzen D.F., Noren Hooten N., De S., Wood W.H., 3rd, Zhang Y., Becker K.G., Zonderman A.B., Tanaka T., Ferrucci L., Evans M.K. Extracellular RNA Profiles with Human Age. Aging Cell. 2018;17:e12785. doi: 10.1111/acel.12785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12785</ArticleId><ArticleId IdType="pmc">PMC6052399</ArticleId><ArticleId IdType="pubmed">29797538</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K., Chen D., Wang Z., Ma J., Zhou J., Chen N., Lv L., Zheng Y., Hu X., Zhang Y., et al. Annotation and Functional Clustering of circRNA Expression in Rhesus Macaque Brain During Aging. Cell Discov. 2018;4:48. doi: 10.1038/s41421-018-0050-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-018-0050-1</ArticleId><ArticleId IdType="pmc">PMC6141548</ArticleId><ArticleId IdType="pubmed">30245844</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Okada S., Sakurai M. Adenosine-to-Inosine RNA Editing in Neurological Development and Disease. RNA Biol. 2021;18:999&#x2013;1013. doi: 10.1080/15476286.2020.1867797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2020.1867797</ArticleId><ArticleId IdType="pmc">PMC8216190</ArticleId><ArticleId IdType="pubmed">33393416</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg E., Levanon E.Y. A-to-I RNA Editing&#x2014;Immune Protector and Transcriptome Diversifier. Nat. Rev. Genet. 2018;19:473&#x2013;490. doi: 10.1038/s41576-018-0006-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-018-0006-1</ArticleId><ArticleId IdType="pubmed">29692414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzini I., Moore S., Sattler R. RNA Editing Deficiency in Neurodegeneration. Adv. Neurobiol. 2018;20:63&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">29916016</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon O., Di Segni A., Cesarkas K., Porath H.T., Marcu-Malina V., Mizrahi O., Stern-Ginossar N., Kol N., Farage-Barhom S., Glick-Saar E., et al. RNA Editing by ADAR1 Leads to Context-Dependent Transcriptome-Wide Changes in RNA Secondary Structure. Nat. Commun. 2017;8:1440. doi: 10.1038/s41467-017-01458-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01458-8</ArticleId><ArticleId IdType="pmc">PMC5682290</ArticleId><ArticleId IdType="pubmed">29129909</ArticleId></ArticleIdList></Reference><Reference><Citation>Montano M., Long K. RNA Surveillance-an Emerging Role for RNA Regulatory Networks in Aging. Ageing Res. Rev. 2011;10:216&#x2013;224. doi: 10.1016/j.arr.2010.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2010.02.002</ArticleId><ArticleId IdType="pmc">PMC2894286</ArticleId><ArticleId IdType="pubmed">20170753</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlstedt H., Daniel C., Enster&#xf6; M., Ohman M. Large-Scale mRNA Sequencing Determines Global Regulation of RNA Editing During Brain Development. Genome Res. 2009;19:978&#x2013;986. doi: 10.1101/gr.089409.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.089409.108</ArticleId><ArticleId IdType="pmc">PMC2694479</ArticleId><ArticleId IdType="pubmed">19420382</ArticleId></ArticleIdList></Reference><Reference><Citation>Shtrichman R., Germanguz I., Mandel R., Ziskind A., Nahor I., Safran M., Osenberg S., Sherf O., Rechavi G., Itskovitz-Eldor J. Altered A-to-I RNA Editing in Human Embryogenesis. PLoS ONE. 2012;7:e41576. doi: 10.1371/journal.pone.0041576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0041576</ArticleId><ArticleId IdType="pmc">PMC3409221</ArticleId><ArticleId IdType="pubmed">22859999</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosaka T., Tsuji H., Kwak S. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases. Int. J. Mol. Sci. 2021;22:10958. doi: 10.3390/ijms222010958.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222010958</ArticleId><ArticleId IdType="pmc">PMC8536083</ArticleId><ArticleId IdType="pubmed">34681616</ArticleId></ArticleIdList></Reference><Reference><Citation>Slotkin W., Nishikura K. Adenosine-to-Inosine RNA Editing and Human Disease. Genome Med. 2013;5:105. doi: 10.1186/gm508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gm508</ArticleId><ArticleId IdType="pmc">PMC3979043</ArticleId><ArticleId IdType="pubmed">24289319</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan T.Y., Sedm&#xed;k J., Fitzgerald M.P., Halevy R.S., Keegan L.P., Helbig I., Basel-Salmon L., Cohen L., Straussberg R., Chung W.K., et al. Bi-allelic ADARB1 Variants Associated with Microcephaly, Intellectual Disability, and Seizures. Am. J. Hum. Genet. 2020;106:467&#x2013;483. doi: 10.1016/j.ajhg.2020.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2020.02.015</ArticleId><ArticleId IdType="pmc">PMC7118584</ArticleId><ArticleId IdType="pubmed">32220291</ArticleId></ArticleIdList></Reference><Reference><Citation>Maroofian R., Sedm&#xed;k J., Mazaheri N., Scala M., Zaki M.S., Keegan L.P., Azizimalamiri R., Issa M., Shariati G., Sedaghat A., et al. Biallelic Variants in ADARB1, Encoding a dsRNA-Specific Adenosine Deaminase, Cause a Severe Developmental and Epileptic Encephalopathy. J. Med. Genet. 2021;58:495&#x2013;504. doi: 10.1136/jmedgenet-2020-107048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2020-107048</ArticleId><ArticleId IdType="pmc">PMC8327408</ArticleId><ArticleId IdType="pubmed">32719099</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston J.H., Lin J.P., Dale R.C., Gill D., Brogan P., Munnich A., Kurian M.A., Gonzalez-Martinez V., De Goede C.G., Falconer A., et al. A Type I Interferon Signature Identifies Bilateral Striatal Necrosis Due to Mutations in ADAR1. J. Med. Genet. 2014;51:76&#x2013;82. doi: 10.1136/jmedgenet-2013-102038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2013-102038</ArticleId><ArticleId IdType="pubmed">24262145</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholas A., de Magalhaes J.P., Kraytsberg Y., Richfield E.K., Levanon E.Y., Khrapko K. Age-Related Gene-Specific Changes of A-to-I mRNA Editing in the Human Brain. Mech. Ageing Dev. 2010;131:445&#x2013;447. doi: 10.1016/j.mad.2010.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2010.06.001</ArticleId><ArticleId IdType="pmc">PMC2915444</ArticleId><ArticleId IdType="pubmed">20538013</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes A.P., Wood S.H., Merry B.J., de Magalh&#xe3;es J.P. A-to-I RNA Editing Does Not Change with Age in the Healthy Male Rat Brain. Biogerontology. 2013;14:395&#x2013;400. doi: 10.1007/s10522-013-9433-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-013-9433-8</ArticleId><ArticleId IdType="pmc">PMC3739863</ArticleId><ArticleId IdType="pubmed">23708854</ArticleId></ArticleIdList></Reference><Reference><Citation>Dube U., Del-Aguila J.L., Li Z., Budde J.P., Jiang S., Hsu S., Ibanez L., Fernandez M.V., Farias F., Norton J., et al. An Atlas of Cortical Circular RNA Expression in Alzheimer Disease Brains Demonstrates Clinical and Pathological Associations. Nat. Neurosci. 2019;22:1903&#x2013;1912. doi: 10.1038/s41593-019-0501-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0501-5</ArticleId><ArticleId IdType="pmc">PMC6858549</ArticleId><ArticleId IdType="pubmed">31591557</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquilina-Reid C., Brennan S., Curry-Hyde A., Teunisse G.M., The Nygc Als Consortium. Janitz M. Circular RNA Expression and Interaction Patterns Are Perturbed in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2022;23:14665. doi: 10.3390/ijms232314665.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232314665</ArticleId><ArticleId IdType="pmc">PMC9739162</ArticleId><ArticleId IdType="pubmed">36498994</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitsipatis D., Mazan-Mamczarz K., Si Y., Herman A.B., Yang J.H., Guha A., Piao Y., Fan J., Martindale J.L., Munk R., et al. Transcriptomic Analysis of Human ALS Skeletal Muscle Reveals a Disease-Specific Pattern of Dysregulated circRNAs. Aging. 2022;14:9832&#x2013;9859. doi: 10.18632/aging.204450.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.204450</ArticleId><ArticleId IdType="pmc">PMC9831722</ArticleId><ArticleId IdType="pubmed">36585921</ArticleId></ArticleIdList></Reference><Reference><Citation>Assoni A.F., Foijer F., Zatz M. Amyotrophic Lateral Sclerosis, FUS and Protein Synthesis Defects. Stem Cell Rev. Rep. 2023;19:625&#x2013;638. doi: 10.1007/s12015-022-10489-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-022-10489-8</ArticleId><ArticleId IdType="pubmed">36515764</ArticleId></ArticleIdList></Reference><Reference><Citation>Errichelli L., Dini Modigliani S., Laneve P., Colantoni A., Legnini I., Capauto D., Rosa A., De Santis R., Scarf&#xf2; R., Peruzzi G., et al. FUS Affects Circular RNA Expression in Murine Embryonic Stem Cell-Derived Motor Neurons. Nat. Commun. 2017;8:14741. doi: 10.1038/ncomms14741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14741</ArticleId><ArticleId IdType="pmc">PMC5379105</ArticleId><ArticleId IdType="pubmed">28358055</ArticleId></ArticleIdList></Reference><Reference><Citation>Colantoni A., Capauto D., Alfano V., D&#x2019;Ambra E., D&#x2019;Uva S., Tartaglia G.G., Morlando M. FUS Alters circRNA Metabolism in Human Motor Neurons Carrying the ALS-Linked P525L Mutation. Int. J. Mol. Sci. 2023;24:3181. doi: 10.3390/ijms24043181.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24043181</ArticleId><ArticleId IdType="pmc">PMC9968238</ArticleId><ArticleId IdType="pubmed">36834591</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer J.D., Isaacs A.M., Mizielinska S., Mead S., Lashley T., Wray S., Sidle K., Fratta P., Orrell R.W., Hardy J., et al. C9orf72 Expansions in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Lancet Neurol. 2015;14:291&#x2013;301. doi: 10.1016/S1474-4422(14)70233-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70233-9</ArticleId><ArticleId IdType="pubmed">25638642</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Latallo M.J., Zhang Z., Huang B., Bobrovnikov D.G., Dong D., Livingston N.M., Tjoeng W., Hayes L.R., Rothstein J.D., et al. Nuclear Export and Translation of Circular Repeat-Containing Intronic RNA in C9ORF72-ALS/FTD. Nat. Commun. 2021;12:4908. doi: 10.1038/s41467-021-25082-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25082-9</ArticleId><ArticleId IdType="pmc">PMC8363653</ArticleId><ArticleId IdType="pubmed">34389711</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil V.V., Katzman R.B., Petrucelli L. ALS and FTD: An Epigenetic Perspective. Acta Neuropathol. 2016;132:487&#x2013;502. doi: 10.1007/s00401-016-1587-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1587-4</ArticleId><ArticleId IdType="pmc">PMC5138862</ArticleId><ArticleId IdType="pubmed">27282474</ArticleId></ArticleIdList></Reference><Reference><Citation>Leighton G.O., Irvin E.M., Kaur P., Liu M., You C., Bhattaram D., Piehler J., Riehn R., Wang H., Pan H., et al. Densely Methylated DNA Traps Methyl-CpG-Binding Domain Protein 2 but Permits Free Diffusion by Methyl-CpG-Binding Domain Protein 3. J. Biol. Chem. 2022;298:102428. doi: 10.1016/j.jbc.2022.102428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.102428</ArticleId><ArticleId IdType="pmc">PMC9520026</ArticleId><ArticleId IdType="pubmed">36037972</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Liu W., Chen X., Yin J., Ma L., Liu M., Zhou X., Xian L., Li P., Tan X., et al. circKCNN2 Suppresses the Recurrence of Hepatocellular Carcinoma at Least Partially via Regulating miR-520c-3p/methyl-DNA-binding Domain Protein 2 Axis. Clin. Transl. Med. 2022;12:e662. doi: 10.1002/ctm2.662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.662</ArticleId><ArticleId IdType="pmc">PMC8775140</ArticleId><ArticleId IdType="pubmed">35051313</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervera-Carles L., Dols-Icardo O., Molina-Porcel L., Alcolea D., Cervantes-Gonzalez A., Mu&#xf1;oz-Llahuna L., Clarimon J. Assessing Circular RNAs in Alzheimer&#x2019;s Disease and Frontotemporal Lobar Degeneration. Neurobiol. Aging. 2020;92:7&#x2013;11. doi: 10.1016/j.neurobiolaging.2020.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.03.017</ArticleId><ArticleId IdType="pubmed">32335360</ArticleId></ArticleIdList></Reference><Reference><Citation>Barznegar M., Rahimi K., Mahdavi P., Menbari M.N., Darvishi N., Vahabzadeh Z., Hakhamaneshi M.S., Andalibi P., Abdi M. Relation Between the Circular and Linear Form of the Elongator Acetyltransferase Complex Subunit 3 in the Progression of Triple-Negative Breast Cancer. Cell Biochem. Funct. 2022;40:550&#x2013;558. doi: 10.1002/cbf.3724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.3724</ArticleId><ArticleId IdType="pubmed">35722999</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Lu J., Duan J., Su D., Hou X., Li F., Wang X., Huang B. Gcn5- and Elp3-Induced Histone H3 Acetylation Regulates hsp70 Gene Transcription in Yeast. Biochem. J. 2008;409:779&#x2013;788. doi: 10.1042/BJ20070578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20070578</ArticleId><ArticleId IdType="pubmed">17910533</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie B., Zhao Z., Liu Q., Wang X., Ma Z., Li H. CircRNA has_circ_0078710 Acts as the Sponge of microRNA-31 Involved in Hepatocellular Carcinoma Progression. Gene. 2019;683:253&#x2013;261. doi: 10.1016/j.gene.2018.10.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.10.043</ArticleId><ArticleId IdType="pubmed">30342168</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang L., Yang M., Wu C., Lan R., Wang W., Li Y. Circ-SIRT1 Inhibits Cardiac Hypertrophy via Activating SIRT1 to Promote Autophagy. Cell Death Dis. 2021;12:1069. doi: 10.1038/s41419-021-04059-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-04059-y</ArticleId><ArticleId IdType="pmc">PMC8580993</ArticleId><ArticleId IdType="pubmed">34759275</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle C., Salvatori I., Gerbino V., Rossi S., Palamiuc L., Ren&#xe9; F., Carr&#xec; M.T. Tissue-Specific Deregulation of Selected HDACs Characterizes ALS Progression in Mouse Models: Pharmacological Characterization of SIRT1 and SIRT2 Pathways. Cell Death Dis. 2014;5:e1296. doi: 10.1038/cddis.2014.247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.247</ArticleId><ArticleId IdType="pmc">PMC4611720</ArticleId><ArticleId IdType="pubmed">24946089</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K., Bennett S.A., Rana N., Yousuf H., Said M., Taaseen S., Mendo N., Meltser S.M., Torrente M.P. Neurodegenerative Disease Proteinopathies Are Connected to Distinct Histone Post-translational Modification Landscapes. ACS Chem. Neurosci. 2018;9:838&#x2013;848. doi: 10.1021/acschemneuro.7b00297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.7b00297</ArticleId><ArticleId IdType="pmc">PMC5906139</ArticleId><ArticleId IdType="pubmed">29243911</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J., Wu Y., He Y. Silencing circRNA LRP6 Down-Regulates PRMT1 to Improve the Streptozocin-Induced Pancreatic Beta-Cell Injury and Insulin Secretion by Sponging miR-9-5p. J. Bioenerg. Biomembr. 2021;53:333&#x2013;342. doi: 10.1007/s10863-021-09895-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10863-021-09895-3</ArticleId><ArticleId IdType="pubmed">33826088</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun M.H., Ryu H.H., Jun Y.W., Liu T., Li Y., Lim C.S., Lee Y.S., Kaang B.K., Jang D.J., Lee J.A. Sequestration of PRMT1 and Nd1-L mRNA into ALS-Linked FUS Mutant R521C-Positive Aggregates Contributes to Neurite Degeneration upon Oxidative Stress. Sci. Rep. 2017;7:40474. doi: 10.1038/srep40474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep40474</ArticleId><ArticleId IdType="pmc">PMC5240339</ArticleId><ArticleId IdType="pubmed">28094300</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Dewil M., Robberecht W., Van Den Bosch L. Excitotoxicity and Amyotrophic Lateral Sclerosis. Neurodegener. Dis. 2005;2:147&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">16909020</ArticleId></ArticleIdList></Reference><Reference><Citation>King A.E., Woodhouse A., Kirkcaldie M.T., Vickers J.C. Excitotoxicity in ALS: Overstimulation, or Overreaction? Exp. Neurol. 2016;275:162&#x2013;171. doi: 10.1016/j.expneurol.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.019</ArticleId><ArticleId IdType="pubmed">26584004</ArticleId></ArticleIdList></Reference><Reference><Citation>Diering G.H., Huganir R.L. The AMPA Receptor Code of Synaptic Plasticity. Neuron. 2018;100:314&#x2013;329. doi: 10.1016/j.neuron.2018.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.10.018</ArticleId><ArticleId IdType="pmc">PMC6214363</ArticleId><ArticleId IdType="pubmed">30359599</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory J.M., Livesey M.R., McDade K., Selvaraj B.T., Barton S.K., Chandran S., Smith C. Dysregulation of AMPA Receptor Subunit Expression in Sporadic ALS Post-Mortem Brain. J. Pathol. 2020;250:67&#x2013;78. doi: 10.1002/path.5351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5351</ArticleId><ArticleId IdType="pmc">PMC6973025</ArticleId><ArticleId IdType="pubmed">31579943</ArticleId></ArticleIdList></Reference><Reference><Citation>Udagawa T., Fujioka Y., Tanaka M., Honda D., Yokoi S., Riku Y., Ibi D., Nagai T., Yamada K., Watanabe H., et al. FUS Regulates AMPA Receptor Function and FTLD/ALS-Associated Behaviour via GluA1 mRNA Stabilization. Nat. Commun. 2015;6:7098. doi: 10.1038/ncomms8098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8098</ArticleId><ArticleId IdType="pmc">PMC4479014</ArticleId><ArticleId IdType="pubmed">25968143</ArticleId></ArticleIdList></Reference><Reference><Citation>Capauto D., Colantoni A., Lu L., Santini T., Peruzzi G., Biscarini S., Morlando M., Shneider N.A., Caffarelli E., Laneve P., et al. A Regulatory Circuitry Between Gria2, miR-409, and miR-495 Is Affected by ALS FUS Mutation in ESC-Derived Motor Neurons. Mol. Neurobiol. 2018;55:7635&#x2013;7651. doi: 10.1007/s12035-018-0884-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-0884-4</ArticleId><ArticleId IdType="pmc">PMC6132778</ArticleId><ArticleId IdType="pubmed">29430619</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj B.T., Livesey M.R., Zhao C., Gregory J.M., James O.T., Cleary E.M., Chouhan A.K., Gane A.B., Perkins E.M., Dando O., et al. C9ORF72 Repeat Expansion Causes Vulnerability of Motor Neurons to Ca2+-Permeable AMPA Receptor-Mediated Excitotoxicity. Nat. Commun. 2018;9:347. doi: 10.1038/s41467-017-02729-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02729-0</ArticleId><ArticleId IdType="pmc">PMC5783946</ArticleId><ArticleId IdType="pubmed">29367641</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R., Barbagallo P., Farrimond L., Candalija A., Scaber J., Ababneh N.A., Sathyaprakash C., Vowles J., Cowley S.A., Talbot K. Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD. Stem Cell Rep. 2020;14:892&#x2013;908. doi: 10.1016/j.stemcr.2020.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.03.023</ArticleId><ArticleId IdType="pmc">PMC7220989</ArticleId><ArticleId IdType="pubmed">32330447</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovinovic A., Greig J., Mart&#xed;n-Guerrero S.M., Salam S., Paillusson S. Endoplasmic Reticulum-Mitochondria Signaling in Neurons and Neurodegenerative Diseases. J. Cell Sci. 2022;135:jcs248534. doi: 10.1242/jcs.248534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.248534</ArticleId><ArticleId IdType="pubmed">35129196</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Ilieva H., Tamada H., Nomura H., Komine O., Endo F., Jin S., Mancias P., Kiyama H., Yamanaka K. Mitochondria-Associated Membrane Collapse Is a Common Pathomechanism in SIGMAR1- and SOD1-Linked ALS. EMBO Mol. Med. 2016;8:1421&#x2013;1437. doi: 10.15252/emmm.201606403.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606403</ArticleId><ArticleId IdType="pmc">PMC5167132</ArticleId><ArticleId IdType="pubmed">27821430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau D.H.W., Hartopp N., Welsh N.J., Mueller S., Glennon E.B., M&#xf3;rotz G.M., Annibali A., Gomez-Suaga P., Stoica R., Paillusson S., et al. Disruption of ER-Mitochondria Signalling in Fronto-temporal Dementia and Related Amyotrophic Lateral Sclerosis. Cell Death Dis. 2018;9:327. doi: 10.1038/s41419-017-0022-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0022-7</ArticleId><ArticleId IdType="pmc">PMC5832427</ArticleId><ArticleId IdType="pubmed">29491392</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakai S., Watanabe S., Komine O., Sobue A., Yamanaka K. Novel Reporters of Mitochondria-Associated Membranes (MAM), MAMtrackers, Demonstrate MAM Disruption as a Common Pathological Feature in Amyotrophic Lateral Sclerosis. FASEB J. 2021;35:e21688. doi: 10.1096/fj.202100137R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202100137R</ArticleId><ArticleId IdType="pubmed">34143516</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A., Al-Mohanna F., Bohlega S. A Mutation in Sigma-1 Receptor Causes Juvenile Amyotrophic Lateral Sclerosis. Ann. Neurol. 2011;70:913&#x2013;919. doi: 10.1002/ana.22534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagashira H., Shinoda Y., Shioda N., Fukunaga K. Methyl Pyruvate Rescues Mitochondrial Damage Caused by SIGMAR1 Mutation Related to Amyotrophic Lateral Sclerosis. Biochim. Biophys. Acta. 2014;1840:3320&#x2013;3334. doi: 10.1016/j.bbagen.2014.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2014.08.012</ArticleId><ArticleId IdType="pubmed">25175561</ArticleId></ArticleIdList></Reference><Reference><Citation>Luty A.A., Kwok J.B., Dobson-Stone C., Loy C.T., Coupland K.G., Karlstr&#xf6;m H., Sobow T., Tchorzewska J., Maruszak A., Barcikowska M., et al. Sigma Nonopioid Intracellular Receptor 1 Mutations Cause Frontotemporal Lobar Degeneration-Motor Neuron Disease. Ann. Neurol. 2010;68:639&#x2013;649. doi: 10.1002/ana.22274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22274</ArticleId><ArticleId IdType="pubmed">21031579</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreser A., Vollrath J.T., Sechi A., Johann S., Roos A., Yamoah A., Katona I., Bohlega S., Wiemuth D., Tian Y., et al. The ALS-Linked E102Q Mutation in Sigma Receptor-1 Leads to ER Stress-Mediated Defects in Protein Homeostasis and Dysregulation of RNA-Binding Proteins. Cell Death Differ. 2017;24:1655&#x2013;1671. doi: 10.1038/cdd.2017.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2017.88</ArticleId><ArticleId IdType="pmc">PMC5596426</ArticleId><ArticleId IdType="pubmed">28622300</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang R., Zhang Y., Han B., Bai Y., Zhou R., Gan G., Chao J., Hu G., Yao H. Circular RNA HIPK2 Regulates Astrocyte Activation via Cooperation of Autophagy and ER Stress by Targeting MIR124-2HG. Autophagy. 2017;13:1722&#x2013;1741. doi: 10.1080/15548627.2017.1356975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1356975</ArticleId><ArticleId IdType="pmc">PMC5640207</ArticleId><ArticleId IdType="pubmed">28786753</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Liu Y., Xu P.P., Zhang X., Talifu Z., Liu J.Y., Jing Y.L., Bai F., Zhao L.X., Yu Y., et al. Inhibition by rno-circRNA-013017 of the Apoptosis of Motor Neurons in Anterior Horn and Descending Axonal Degeneration in Rats After Traumatic Spinal Cord Injury. Front. Neurosci. 2022;16:1065897. doi: 10.3389/fnins.2022.1065897.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.1065897</ArticleId><ArticleId IdType="pmc">PMC9797719</ArticleId><ArticleId IdType="pubmed">36590290</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaitakis A., Constantakakis E., Smith J. The Neuroexcitotoxic Amino Acids Glutamate and Aspartate Are Altered in the Spinal Cord and Brain in Amyotrophic Lateral Sclerosis. Ann. Neurol. 1988;24:446&#x2013;449. doi: 10.1002/ana.410240314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410240314</ArticleId><ArticleId IdType="pubmed">2906529</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., Coyle J.T. Abnormal Excitatory Amino Acid Metabolism in Amyotrophic Lateral Sclerosis. Ann. Neurol. 1990;28:18&#x2013;25. doi: 10.1002/ana.410280106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410280106</ArticleId><ArticleId IdType="pubmed">2375630</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw P.J., Forrest V., Ince P.G., Richardson J.P., Wastell H.J. CSF and Plasma Amino Acid Levels in Motor Neuron Disease: Elevation of CSF Glutamate in a Subset of Patients. Neurodegeneration. 1995;4:209&#x2013;216. doi: 10.1006/neur.1995.0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/neur.1995.0026</ArticleId><ArticleId IdType="pubmed">7583686</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreux-Varoquaux O., Bensimon G., Lacomblez L., Salachas F., Pradat P.F., Le Forestier N., Marouan A., Dib M., Meininger V. Glutamate Levels in Cerebrospinal Fluid in Amyotrophic Lateral Sclerosis: A Reappraisal Using a New HPLC Method with Coulometric Detection in a Large Cohort of Patients. J. Neurol. Sci. 2002;193:73&#x2013;78. doi: 10.1016/S0022-510X(01)00661-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00661-X</ArticleId><ArticleId IdType="pubmed">11790386</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D., Martin L.J., Kuncl R.W. Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 1992;326:1464&#x2013;1468. doi: 10.1056/NEJM199205283262204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199205283262204</ArticleId><ArticleId IdType="pubmed">1349424</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin D., Thompson M.A., Nadler J.V. The Neuroprotective Agent Riluzole Inhibits Release of Glutamate and Aspartate from Slices of Hippocampal Area CA1. Eur. J. Pharmacol. 1993;250:473&#x2013;476. doi: 10.1016/0014-2999(93)90037-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-2999(93)90037-I</ArticleId><ArticleId IdType="pubmed">8112408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G., Lacomblez L., Meininger V. A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med. 1994;330:585&#x2013;591. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T., Al Khleifat A., Meurgey J.H., Jones A., Leigh P.N., Bensimon G., Al-Chalabi A. Stage at Which Riluzole Treatment Prolongs Survival in Patients with Amyotrophic Lateral Sclerosis: A Retrospective Analysis of Data from a Dose-Ranging Study. Lancet Neurol. 2018;17:416&#x2013;422. doi: 10.1016/S1474-4422(18)30054-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30054-1</ArticleId><ArticleId IdType="pmc">PMC5899963</ArticleId><ArticleId IdType="pubmed">29525492</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldmeyer D., Kask K., Brusa R., Kornau H.C., Kolhekar R., Rozov A., Burnashev N., Jensen V., Hvalby O., Sprengel R., et al. Neurological Dysfunctions in Mice Expressing Different Levels of the Q/R Site-Unedited AMPAR Subunit GluR-B. Nat. Neurosci. 1999;2:57&#x2013;64. doi: 10.1038/4561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/4561</ArticleId><ArticleId IdType="pubmed">10195181</ArticleId></ArticleIdList></Reference><Reference><Citation>Higuchi M., Maas S., Single F.N., Hartner J., Rozov A., Burnashev N., Feldmeyer D., Sprengel R., Seeburg P.H. Point Mutation in an AMPA Receptor Gene Rescues Lethality in Mice Deficient in the RNA-Editing Enzyme ADAR2. Nature. 2000;406:78&#x2013;81. doi: 10.1038/35017558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35017558</ArticleId><ArticleId IdType="pubmed">10894545</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeburg P.H. A-to-I Editing: New and Old Sites, Functions and Speculations. Neuron. 2002;35:17&#x2013;20. doi: 10.1016/S0896-6273(02)00760-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00760-2</ArticleId><ArticleId IdType="pubmed">12123604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y., Ito K., Sun H., Aizawa H., Kanazawa I., Kwak S. Glutamate Receptors: RNA Editing and Death of Motor Neurons. Nature. 2004;427:801. doi: 10.1038/427801a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/427801a</ArticleId><ArticleId IdType="pubmed">14985749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hideyama T., Yamashita T., Aizawa H., Tsuji S., Kakita A., Takahashi H., Kwak S. Profound Downregulation of the RNA Editing Enzyme ADAR2 in ALS Spinal Motor Neurons. Neurobiol. Dis. 2012;45:1121&#x2013;1128. doi: 10.1016/j.nbd.2011.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.12.033</ArticleId><ArticleId IdType="pubmed">22226999</ArticleId></ArticleIdList></Reference><Reference><Citation>Hideyama T., Yamashita T., Suzuki T., Tsuji S., Higuchi M., Seeburg P.H., Takahashi R., Misawa H., Kwak S. Induced Loss of ADAR2 Engenders Slow Death of Motor Neurons from Q/R Site-Unedited GluR2. J. Neurosci. 2010;30:11917&#x2013;11925. doi: 10.1523/JNEUROSCI.2021-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2021-10.2010</ArticleId><ArticleId IdType="pmc">PMC6633551</ArticleId><ArticleId IdType="pubmed">20826656</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T., Hideyama T., Hachiga K., Teramoto S., Takano J., Iwata N., Saido T.C., Kwak S. A Role for Calpain-Dependent Cleavage of TDP-43 in Amyotrophic Lateral Sclerosis Pathology. Nat. Commun. 2012;3:1307. doi: 10.1038/ncomms2303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2303</ArticleId><ArticleId IdType="pubmed">23250437</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T., Kwak S. The Molecular Link Between Inefficient GluA2 Q/R Site-RNA Editing and TDP-43 Pathology in Motor Neurons of Sporadic Amyotrophic Lateral Sclerosis Patients. Brain Res. 2014;1584:28&#x2013;38. doi: 10.1016/j.brainres.2013.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.12.011</ArticleId><ArticleId IdType="pubmed">24355598</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y., Sun H., Ito K., Hideyama T., Aoki M., Sobue G., Tsuji S., Kwak S. Underediting of GluR2 mRNA, a Neuronal Death Inducing Molecular Change in Sporadic ALS, Does Not Occur in Motor Neurons in ALS1 or SBMA. Neurosci. Res. 2006;54:11&#x2013;14. doi: 10.1016/j.neures.2005.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2005.09.006</ArticleId><ArticleId IdType="pubmed">16225946</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizawa H., Sawada J., Hideyama T., Yamashita T., Katayama T., Hasebe N., Kimura T., Yahara O., Kwak S. TDP-43 Pathology in Sporadic ALS Occurs in Motor Neurons Lacking the RNA Editing Enzyme ADAR2. Acta Neuropathol. 2010;120:75&#x2013;84. doi: 10.1007/s00401-010-0678-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0678-x</ArticleId><ArticleId IdType="pubmed">20372915</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett S.A., Tanaz R., Cobos S.N., Torrente M.P. Epigenetics in Amyotrophic Lateral Sclerosis: A Role for Histone Post-translational Modifications in Neurodegenerative Disease. Transl. Res. 2019;204:19&#x2013;30. doi: 10.1016/j.trsl.2018.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2018.10.002</ArticleId><ArticleId IdType="pmc">PMC6331271</ArticleId><ArticleId IdType="pubmed">30391475</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida H., Ito S. Differential Regulation of Expression of RNA-Editing Enzymes, ADAR1 and ADAR2, by 5-aza-2&#x2032;-deoxycytidine and Trichostatin A in Human Neuronal SH-SY5Y Cells. NeuroReport. 2015;26:1089&#x2013;1094. doi: 10.1097/WNR.0000000000000474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNR.0000000000000474</ArticleId><ArticleId IdType="pubmed">26485095</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizawa H., Hideyama T., Yamashita T., Kimura T., Suzuki N., Aoki M., Kwak S. Deficient RNA-Editing Enzyme ADAR2 in an Amyotrophic Lateral Sclerosis Patient with a FUS(P525L) Mutation. J. Clin. Neurosci. 2016;32:128&#x2013;129. doi: 10.1016/j.jocn.2015.12.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2015.12.039</ArticleId><ArticleId IdType="pubmed">27343041</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore S., Alsop E., Lorenzini I., Starr A., Rabichow B.E., Mendez E., Levy J.L., Burciu C., Reiman R., Chew J., et al. ADAR2 Mislocalization and Widespread RNA Editing Aberrations in C9orf72-Mediated ALS/FTD. Acta Neuropathol. 2019;138:49&#x2013;65. doi: 10.1007/s00401-019-01999-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01999-w</ArticleId><ArticleId IdType="pmc">PMC6750285</ArticleId><ArticleId IdType="pubmed">30945056</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Matsuoka M. Proline-Arginine Poly-dipeptide Encoded by the C9orf72 Repeat Expansion Inhibits Adenosine Deaminase Acting on RNA. J. Neurochem. 2021;158:753&#x2013;765. doi: 10.1111/jnc.15445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15445</ArticleId><ArticleId IdType="pubmed">34081786</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Xue W., Li X., Zhang J., Chen S., Zhang J.L., Yang L., Chen L.L. The Biogenesis of Nascent Circular RNAs. Cell Rep. 2016;15:611&#x2013;624. doi: 10.1016/j.celrep.2016.03.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.03.058</ArticleId><ArticleId IdType="pubmed">27068474</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.O., Wang H.B., Zhang Y., Lu X., Chen L.L., Yang L. Complementary Sequence-Mediated Exon Circularization. Cell. 2014;159:134&#x2013;147. doi: 10.1016/j.cell.2014.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.09.001</ArticleId><ArticleId IdType="pubmed">25242744</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung H., Calis J.J.A., Wu X., Sun T., Yu Y., Sarbanes S.L., Dao Thi V.L., Shilvock A.R., Hoffmann H.H., Rosenberg B.R., et al. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown. Cell. 2018;172:811&#x2013;824.e14. doi: 10.1016/j.cell.2017.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.038</ArticleId><ArticleId IdType="pmc">PMC5831367</ArticleId><ArticleId IdType="pubmed">29395325</ArticleId></ArticleIdList></Reference><Reference><Citation>Akta&#x15f; T., Av&#x15f;ar Il&#x131;k &#x130;., Maticzka D., Bhardwaj V., Pessoa Rodrigues C., Mittler G., Manke T., Backofen R., Akhtar A. DHX9 Suppresses RNA Processing Defects Originating from the Alu Invasion of the Human Genome. Nature. 2017;544:115&#x2013;119. doi: 10.1038/nature21715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21715</ArticleId><ArticleId IdType="pubmed">28355180</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C., Wang X., Yang F., Zang Y., Liu J., Wang X., Xu X., Li W., Jia J., Liu Z. Circular RNA hsa_circ_0004872 Inhibits Gastric Cancer Progression via the miR-224/Smad4/ADAR1 Successive Regulatory Circuit. Mol. Cancer. 2020;19:157. doi: 10.1186/s12943-020-01268-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-020-01268-5</ArticleId><ArticleId IdType="pmc">PMC7654041</ArticleId><ArticleId IdType="pubmed">33172486</ArticleId></ArticleIdList></Reference><Reference><Citation>Omata Y., Okawa M., Haraguchi M., Tsuruta A., Matsunaga N., Koyanagi S., Ohdo S. RNA Editing Enzyme ADAR1 Controls miR-381-3p-mediated Expression of Multidrug Resistance Protein MRP4 via Regulation of circRNA in Human Renal Cells. J. Biol. Chem. 2022;298:102184. doi: 10.1016/j.jbc.2022.102184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.102184</ArticleId><ArticleId IdType="pmc">PMC9293778</ArticleId><ArticleId IdType="pubmed">35753353</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosaka T., Yamashita T., Teramoto S., Hirose N., Tamaoka A., Kwak S. ADAR2-Dependent A-to-I RNA Editing in the Extracellular Linear and Circular RNAs. Neurosci. Res. 2019;147:48&#x2013;57. doi: 10.1016/j.neures.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2018.11.005</ArticleId><ArticleId IdType="pubmed">30448461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokot K.E., Kneuer J.M., John D., Rebs S., M&#xf6;bius-Winkler M.N., Erbe S., M&#xfc;ller M., Andritschke M., Gaul S., Sheikh B.N., et al. Reduction of A-to-I RNA Editing in the Failing Human Heart Regulates Formation of Circular RNAs. Basic Res. Cardiol. 2022;117:32. doi: 10.1007/s00395-022-00940-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-022-00940-9</ArticleId><ArticleId IdType="pmc">PMC9226085</ArticleId><ArticleId IdType="pubmed">35737129</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E., Kim Y.K., Lee S.V. Emerging Functions of Circular RNA in Aging. Trends Genet. 2021;37:819&#x2013;829. doi: 10.1016/j.tig.2021.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2021.04.014</ArticleId><ArticleId IdType="pubmed">34016449</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolinar A., Koritnik B., Glava&#x10d; D., Ravnik-Glava&#x10d; M. Circular RNAs as Potential Blood Biomarkers in Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2019;56:8052&#x2013;8062. doi: 10.1007/s12035-019-1627-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1627-x</ArticleId><ArticleId IdType="pmc">PMC6834740</ArticleId><ArticleId IdType="pubmed">31175544</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D., Droppelmann C.A., He Z., Volkening K., Strong M.J. Altered microRNA Expression Profile in Amyotrophic Lateral Sclerosis: A Role in the Regulation of NFL mRNA Levels. Mol. Brain. 2013;6:26. doi: 10.1186/1756-6606-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-26</ArticleId><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrabec K., Bo&#x161;tjan&#x10d;i&#x10d; E., Koritnik B., Leonardis L., Dolenc Gro&#x161;elj L., Zidar J., Rogelj B., Glava&#x10d; D., Ravnik-Glava&#x10d; M. Differential Expression of Several miRNAs and the Host Genes AATK and DNM2 in Leukocytes of Sporadic ALS Patients. Front. Mol. Neurosci. 2018;11:106. doi: 10.3389/fnmol.2018.00106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00106</ArticleId><ArticleId IdType="pmc">PMC5893848</ArticleId><ArticleId IdType="pubmed">29670510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravnik-Glava&#x10d; M., Glava&#x10d; D. Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2020;21:1714. doi: 10.3390/ijms21051714.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051714</ArticleId><ArticleId IdType="pmc">PMC7084402</ArticleId><ArticleId IdType="pubmed">32138249</ArticleId></ArticleIdList></Reference><Reference><Citation>Armakola M., Higgins M.J., Figley M.D., Barmada S.J., Scarborough E.A., Diaz Z., Fang X., Shorter J., Krogan N.J., Finkbeiner S., et al. Inhibition of RNA Lariat Debranching Enzyme Suppresses TDP-43 Toxicity in ALS Disease Models. Nat. Genet. 2012;44:1302&#x2013;1309. doi: 10.1038/ng.2434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2434</ArticleId><ArticleId IdType="pmc">PMC3510335</ArticleId><ArticleId IdType="pubmed">23104007</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Adams D.A., Niedzwiecki M.V., Wong M. Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic. Cells. 2022;11:3448. doi: 10.3390/cells11213448.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11213448</ArticleId><ArticleId IdType="pmc">PMC9657572</ArticleId><ArticleId IdType="pubmed">36359844</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Han B., Zhang Z., Wang S., Bai Y., Zhang Y., Tang Y., Du L., Xu L., Wu F., et al. Extracellular Vesicle-Mediated Delivery of Circular RNA SCMH1 Promotes Functional Recovery in Rodent and Nonhuman Primate Ischemic Stroke Models. Circulation. 2020;142:556&#x2013;574. doi: 10.1161/CIRCULATIONAHA.120.045765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.045765</ArticleId><ArticleId IdType="pubmed">32441115</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Bai Y., Han B., Ju M., Tang T., Shen L., Li M., Yang L., Zhang Z., Hu G., et al. Extracellular Vesicle-Mediated Delivery of circDYM Alleviates CUS-Induced Depressive-Like Behaviours. J. Extracell. Vesicles. 2022;11:e12185. doi: 10.1002/jev2.12185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12185</ArticleId><ArticleId IdType="pmc">PMC8758833</ArticleId><ArticleId IdType="pubmed">35029057</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T., Chai H.L., Teramoto S., Tsuji S., Shimazaki K., Muramatsu S., Kwak S. Rescue of Amyotrophic Lateral Sclerosis Phenotype in a Mouse Model by Intravenous AAV9-ADAR2 Delivery to Motor Neurons. EMBO Mol. Med. 2013;5:1710&#x2013;1719. doi: 10.1002/emmm.201302935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201302935</ArticleId><ArticleId IdType="pmc">PMC3840487</ArticleId><ArticleId IdType="pubmed">24115583</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., Zimmerman M.B., Beltz T.G., Johnson A.K. Affect-Related Behaviors in Mice Misexpressing the RNA Editing Enzyme ADAR2. Physiol. Behav. 2009;97:446&#x2013;454. doi: 10.1016/j.physbeh.2009.03.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2009.03.029</ArticleId><ArticleId IdType="pmc">PMC2778280</ArticleId><ArticleId IdType="pubmed">19361536</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C., Berry J.D., McKenna-Yasek D.M., Gernoux G., Owegi M.A., Pothier L.M., Douthwright C.L., Gelevski D., Luppino S.D., Blackwood M., et al. SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS. N. Engl. J. Med. 2020;383:151&#x2013;158. doi: 10.1056/NEJMoa2005056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2005056</ArticleId><ArticleId IdType="pubmed">32640133</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T.M., Cudkowicz M.E., Genge A., Shaw P.J., Sobue G., Bucelli R.C., Chi&#xf2; A., Van Damme P., Ludolph A.C., Glass J.D., et al. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2022;387:1099&#x2013;1110. doi: 10.1056/NEJMoa2204705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2204705</ArticleId><ArticleId IdType="pubmed">36129998</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Andreucci A., Iwamoto N., Yin Y., Yang H., Liu F., Bulychev A., Hu X.S., Lin X., Lamore S., et al. Preclinical Evaluation of WVE-004, Aninvestigational Stereopure Oligonucleotide Forthe Treatment of C9orf72-Associated ALS or FTD. Mol. Ther. Nucleic Acids. 2022;28:558&#x2013;570. doi: 10.1016/j.omtn.2022.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2022.04.007</ArticleId><ArticleId IdType="pmc">PMC9092894</ArticleId><ArticleId IdType="pubmed">35592494</ArticleId></ArticleIdList></Reference><Reference><Citation>George L.A., Sullivan S.K., Giermasz A., Rasko J.E.J., Samelson-Jones B.J., Ducore J., Cuker A., Sullivan L.M., Majumdar S., Teitel J., et al. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant. N. Engl. J. Med. 2017;377:2215&#x2013;2227. doi: 10.1056/NEJMoa1708538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1708538</ArticleId><ArticleId IdType="pmc">PMC6029626</ArticleId><ArticleId IdType="pubmed">29211678</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangarajan S., Walsh L., Lester W., Perry D., Madan B., Laffan M., Yu H., Vettermann C., Pierce G.F., Wong W.Y., et al. AAV5-Factor VIII Gene Transfer in Severe Hemophilia A. N. Engl. J. Med. 2017;377:2519&#x2013;2530. doi: 10.1056/NEJMoa1708483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1708483</ArticleId><ArticleId IdType="pubmed">29224506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima K., Nakajima T., Taga N., Miyauchi A., Kato M., Matsumoto A., Ikeda T., Nakamura K., Kubota T., Mizukami H., et al. Gene Therapy Improves Motor and Mental Function of Aromatic L-Amino Acid Decarboxylase Deficiency. Brain. 2019;142:322&#x2013;333. doi: 10.1093/brain/awy331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy331</ArticleId><ArticleId IdType="pmc">PMC6377184</ArticleId><ArticleId IdType="pubmed">30689738</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendell J.R., Al-Zaidy S., Shell R., Arnold W.D., Rodino-Klapac L.R., Prior T.W., Lowes L., Alfano L., Berry K., Church K., et al. Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N. Engl. J. Med. 2017;377:1713&#x2013;1722. doi: 10.1056/NEJMoa1706198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1706198</ArticleId><ArticleId IdType="pubmed">29091557</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Den Bosch L., Vandenberghe W., Klaassen H., Van Houtte E., Robberecht W. Ca2+-Permeable AMPA Receptors and Selective Vulnerability of Motor Neurons. J. Neurol. Sci. 2000;180:29&#x2013;34. doi: 10.1016/S0022-510X(00)00414-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(00)00414-7</ArticleId><ArticleId IdType="pubmed">11090861</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P., Leyssen M., Callewaert G., Robberecht W., Van Den Bosch L. The AMPA Receptor Antagonist NBQX Prolongs Survival in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. Neurosci. Lett. 2003;343:81&#x2013;84. doi: 10.1016/S0304-3940(03)00314-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(03)00314-8</ArticleId><ArticleId IdType="pubmed">12759169</ArticleId></ArticleIdList></Reference><Reference><Citation>Akamatsu M., Yamashita T., Hirose N., Teramoto S., Kwak S. The AMPA Receptor Antagonist Perampanel Robustly Rescues Amyotrophic Lateral Sclerosis (ALS) Pathology in Sporadic ALS Model Mice. Sci. Rep. 2016;6:28649. doi: 10.1038/srep28649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28649</ArticleId><ArticleId IdType="pmc">PMC4923865</ArticleId><ArticleId IdType="pubmed">27350567</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Mauricio E.A., Shah J.S., Li Z., Rogawski M.A. Cortical Excitability Threshold Can Be Increased by the AMPA Blocker Perampanel in Amyotrophic Lateral Sclerosis. Muscle Nerve. 2021;64:215&#x2013;219. doi: 10.1002/mus.27328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27328</ArticleId><ArticleId IdType="pubmed">34008857</ArticleId></ArticleIdList></Reference><Reference><Citation>Akamatsu M., Yamashita T., Teramoto S., Huang Z., Lynch J., Toda T., Niu L., Kwak S. Testing of the Therapeutic Efficacy and Safety of AMPA Receptor RNA Aptamers in an ALS Mouse Model. Life Sci. Alliance. 2022;5:e202101193. doi: 10.26508/lsa.202101193.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202101193</ArticleId><ArticleId IdType="pmc">PMC8761490</ArticleId><ArticleId IdType="pubmed">35022247</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizawa H., Kato H., Oba K., Kawahara T., Okubo Y., Saito T., Naito M., Urushitani M., Tamaoka A., Nakamagoe K., et al. Randomized Phase 2 Study of Perampanel for Sporadic Amyotrophic Lateral Sclerosis. J. Neurol. 2022;269:885&#x2013;896. doi: 10.1007/s00415-021-10670-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10670-y</ArticleId><ArticleId IdType="pmc">PMC8782807</ArticleId><ArticleId IdType="pubmed">34191081</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai M.C., Tzeng R.C., Huang C.W., Wu S.N. The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-Type Potassium Currents. Biomolecules. 2019;9:638. doi: 10.3390/biom9100638.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9100638</ArticleId><ArticleId IdType="pmc">PMC6843791</ArticleId><ArticleId IdType="pubmed">31652643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.E., Choi H.C., Song H.K., Kang T.C. Perampanel Affects Up-Stream Regulatory Signaling Pathways of GluA1 Phosphorylation in Normal and Epileptic Rats. Front. Cell. Neurosci. 2019;13:80. doi: 10.3389/fncel.2019.00080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00080</ArticleId><ArticleId IdType="pmc">PMC6405474</ArticleId><ArticleId IdType="pubmed">30881292</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Zhang D. Memantine Prolongs Survival in an Amyotrophic Lateral Sclerosis Mouse Model. Eur. J. Neurosci. 2005;22:2376&#x2013;2380. doi: 10.1111/j.1460-9568.2005.04431.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2005.04431.x</ArticleId><ArticleId IdType="pubmed">16262676</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho M., Pinto S., Costa J., Evangelista T., Ohana B., Pinto A. A Randomized, Placebo-Controlled Trial of Memantine for Functional Disability in Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. 2010;11:456&#x2013;460. doi: 10.3109/17482968.2010.498521.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.498521</ArticleId><ArticleId IdType="pubmed">20565333</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss M.D., Macklin E.A., Simmons Z., Knox A.S., Greenblatt D.J., Atassi N., Graves M., Parziale N., Salameh J.S., Quinn C., et al. A Randomized Trial of Mexiletine in ALS: Safety and Effects on Muscle Cramps and Progression. Neurology. 2016;86:1474&#x2013;1481. doi: 10.1212/WNL.0000000000002507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002507</ArticleId><ArticleId IdType="pmc">PMC4836879</ArticleId><ArticleId IdType="pubmed">26911633</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss M.D., Macklin E.A., McIlduff C.E., Vucic S., Wainger B.J., Kiernan M.C., Goutman S.A., Goyal N.A., Rutkove S.B., Ladha S.S., et al. Effects of Mexiletine on Hyperexcitability in Sporadic Amyotrophic Lateral Sclerosis: Preliminary Findings from a Small Phase II Randomized Controlled Trial. Muscle Nerve. 2021;63:371&#x2013;383. doi: 10.1002/mus.27146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27146</ArticleId><ArticleId IdType="pmc">PMC8513796</ArticleId><ArticleId IdType="pubmed">33340120</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya K., Misawa S., Kimura H., Noto Y., Sato Y., Sekiguchi Y., Iwai Y., Mitsuma S., Beppu M., Watanabe K., et al. A Single Blind Randomized Controlled Clinical Trial of Mexiletine in Amyotrophic Lateral Sclerosis: Efficacy and Safety of Sodium Channel Blocker Phase II Trial. Amyotroph. Lateral Scler. Front. Degener. 2015;16:353&#x2013;358. doi: 10.3109/21678421.2015.1038277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1038277</ArticleId><ArticleId IdType="pubmed">25960085</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger B.J., Kiskinis E., Mellin C., Wiskow O., Han S.S., Sandoe J., Perez N.P., Williams L.A., Lee S., Boulting G., et al. Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons. Cell Rep. 2014;7:1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger B.J., Macklin E.A., Vucic S., McIlduff C.E., Paganoni S., Maragakis N.J., Bedlack R., Goyal N.A., Rutkove S.B., Lange D.J., et al. Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Neurol. 2021;78:186&#x2013;196. doi: 10.1001/jamaneurol.2020.4300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.4300</ArticleId><ArticleId IdType="pmc">PMC7684515</ArticleId><ArticleId IdType="pubmed">33226425</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>